The flu virus's ability to mutate may sometimes be its downfall
One of influenza virus's main weapons is actually a double-edged sword.
May 31, 2019
0
289
One of influenza virus's main weapons is actually a double-edged sword.
May 31, 2019
0
289
Two experimental vaccines show promise in protecting against infection with the "mono" virus, which also causes cancer and has been implicated as a potential trigger of multiple sclerosis, a new paper reports.
May 8, 2022
0
28
Viruses and other disease-causing microbes influence the type of immune response their hosts will develop against them. In some cases, the predominant response involves antibodies, proteins made by the immune system that ...
Jun 11, 2020
0
222
The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.
Jan 4, 2022
0
292
A multicenter collaboration tracking the spread and evolution of the SARS-CoV-2 virus in Saudi Arabia has identified mutations in the virus's N protein associated with increased viral loads in COVID-19 patients. The study ...
Mar 28, 2022
0
224
The influenza pandemic that began in Mexico in April 2009 rapidly spread throughout the world and arrived in Japan one month later. Now, a research team led by Toshihisa Ishikawa at the RIKEN Omics Science Center in Yokohama ...
Jul 15, 2011
0
0
A research team led by scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) has determined how several antibodies induced by Epstein-Barr virus (EBV), a herpesvirus that causes infectious mononucleosis ...
Apr 9, 2019
0
213
A team of scientists has discovered new insights into the mechanisms of Epstein-Barr virus (EBV) infection, as well as two antibodies that block the virus' entry into cells. The findings, published in Proceedings of the National ...
Oct 18, 2017
0
68
A recent USC study provides new information about why SARS-CoV-2, the virus behind the COVID-19 pandemic, may elicit mild symptoms at first but then, for a subset of patients, turn potentially fatal a week or so after infection. ...
Mar 29, 2024
0
57
Developing and testing a new vaccine typically takes at least 12 to 18 months. However, just over 10 months after the genetic sequence of the SARS-CoV-2 virus was published, two pharmaceutical companies applied for FDA emergency ...
Dec 11, 2020
0
92